Bioequivalence of a Single-dose of 12 mg IVERMECTIN as Orally Disintegrating Mini Tablets Versus a Single-dose of 12 mg Regular IVERMECTIN Tablets in Healthy Adults Under Fasting Conditions
Clinical trial NCT05477810 · COMPLETED
Trial details
- NCT number
- NCT05477810
- Sponsor
- University Children's Hospital Basel
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-13
- Primary completion
- 2022-12-15
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.